Loading clinical trials...

Assisted Partner Services and HIVST in Western Kenya | Clinical Trials | Clareo Health

COMPLETEDNA

Assisted Partner Services and HIVST in Western Kenya

Implementing Assisted Partner Services for HIV Testing and Treatment in Western Kenya

NCT04774835•University of Washington

Summary

This study includes different designs with Aim 1 being a cluster randomized controlled trial to investigate the use of HIV self-testing (HIVST) as a mode of HIV testing in Western Kenya in addition to the standard of care, assisted partner services (aPS). Aim 2 includes focus group discussions, in-depth interviews, semi-structured interviews, direct observation of facility infrastructure and clinic procedures, and data extraction from facility and county/national databases and expenditure reports to study acceptability, costs, and implementation aspects of HIVST within the aPS framework.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Aim 1:
•Men and women
•Tests HIV positive and is not in care or on treatment
•≥18 years old
•Willing and able to provide informed consent
•Able to provide locator information for sexual partners
•Aim 2:
•≥18 years old
•Willing and able to provide informed consent

Exclusion Criteria

•Aim 1:
•Pregnancy
•Reports intimate partner violence during last month
•\<18 years old
•Aim 2:
•\<18 years old

Locations (1)

University of Washington

Seattle, Washington, United States

Key Dates

Start Date

March 1, 2021

Primary Completion Date

July 1, 2022

Completion Date

October 12, 2022

Last Updated

October 19, 2022

Enrollment

4,941

ACTUAL participants

Conditions

Hiv

Interventions

HIVST

DIAGNOSTIC_TEST

Standard aPS

DIAGNOSTIC_TEST

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

NCT07071623

Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis

View study

RECRUITING

Thinking and Memory Problems in People With HIV

NCT01875588

HIV Positive

View study

RECRUITINGPHASE2

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 19, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Assisted Partner Services and HIVST in Western Kenya

Inclusion Criteria

Exclusion Criteria

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Thinking and Memory Problems in People With HIV

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

The LD Lync Study - Natural History Study of Lipodystrophy Syndromes

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption